Effect of Nilotinib on Bleomycin-Induced Acute Lung Injury and Pulmonary Fibrosis in Mice

BACKGROUND: The tyrosine kinase inhibitor imatinib mesylate was developed as an inhibitor of the kinase activity of BCR-ABL. However, imatinib also has potent inhibitory activity against the platelet-derived growth factor receptor (PDGFR). Nilotinib is approved for treating patients with chronic mye...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Respiration
Autori principali: Rhee, Chin Kook, Lee, Sang Haak, Yoon, Hyung Kyu, Kim, Seok Chan, Lee, Sook Young, Kwon, Soon Suk, Kim, Young Kyoon, Kim, Kwan Hyoung, Kim, Tae Jung, Kim, Jin Woo
Natura: Artigo
Lingua:Inglês
Pubblicazione: S. Karger AG 2011
Soggetti:
Basic Science Investigations
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7068797/
https://ncbi.nlm.nih.gov/pubmed/21659722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000327719
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi